Published in Adv Exp Med Biol on January 01, 1986
EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol (2006) 2.86
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology (2005) 2.69
Anticholinergics for symptomatic management of Parkinson's disease. Cochrane Database Syst Rev (2003) 1.91
Report of the task force on designing clinical trials in early (predementia) AD. Neurology (2010) 1.75
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor. J Med Genet (2005) 1.40
Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol (2013) 1.24
Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev (2005) 1.18
Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology (2008) 1.14
Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers. Neurology (2002) 1.07
Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review. Parkinsonism Relat Disord (2009) 1.06
The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm (Vienna) (2005) 1.05
Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology. J Nutr Health Aging (2012) 1.00
Kinin-converting aminopeptidase from human serum. Biochem Pharmacol (1973) 1.00
Botulinum toxin type B for cervical dystonia. Cochrane Database Syst Rev (2005) 0.95
Brachial plexopathy after Botulinum toxin administration for cervical dystonia. J Neurol Neurosurg Psychiatry (1993) 0.94
A behavioral evaluation of PCE exposure in patients and dry cleaners: a possible relationship between clinical and preclinical effects. J Occup Environ Med (1995) 0.92
Purification and characterization of a sulfhydryl-dependent protease from Rhodnius prolixus midgut. Arch Biochem Biophys (1978) 0.92
Skin antiseptics in venous puncture-site disinfection for prevention of blood culture contamination: systematic review with meta-analysis. J Hosp Infect (2010) 0.92
Carla Task Force on Sarcopenia: propositions for clinical trials. J Nutr Health Aging (2009) 0.90
Acute neurobehavioural effects of toluene. Br J Ind Med (1989) 0.90
Botulinum toxin type A therapy for hemifacial spasm. Cochrane Database Syst Rev (2005) 0.90
What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer? Ann Oncol (2009) 0.86
Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures. Cochrane Database Syst Rev (2006) 0.86
Botulinum toxin type A therapy for blepharospasm. Cochrane Database Syst Rev (2005) 0.85
Human plasma kallikrein. Purification and preliminary characterization. Arch Biochem Biophys (1974) 0.85
Perchloroethylene exposure assessment among dry cleaning workers. Am Ind Hyg Assoc J (1990) 0.85
Botulinum toxin type A versus botulinum toxin type B for cervical dystonia. Cochrane Database Syst Rev (2005) 0.84
Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts. Cochrane Database Syst Rev (2006) 0.84
Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers. Eur J Neurol (2006) 0.83
Botulinum toxin type A versus anticholinergics for cervical dystonia. Cochrane Database Syst Rev (2005) 0.83
Synthesis of prekallikrein and metabolism of plasma kallikrein by perfused rat liver. Biochem Pharmacol (1981) 0.81
The invariance of the total direct DNA strand break yield. Med Phys (2011) 0.81
Isolation and characterization of protein kinase C from human placenta. Placenta (1990) 0.80
Involvement of lysine residues in the binding of ovine prolactin and human growth hormone to lactogenic receptors. FEBS Lett (1985) 0.80
Characterization of a kinin-converting arylaminopeptidase from human liver. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.80
Kinin-inactivating endopeptidase from rat liver. Int J Biochem (1984) 0.80
Involvement of lysine residues in the binding of hGH and bGH to somatotropic receptors. FEBS Lett (1985) 0.80
Methionine aminopeptidase associated with liver mitochondria and microsomes. Int J Biochem (1981) 0.80
Dementia and severity of parkinsonism determines the handicap of patients in late-stage Parkinson's disease: the Barcelona-Lisbon cohort. Eur J Neurol (2014) 0.80
Two arylamidases from human liver and their kinin-converting activity. Int J Biochem (1979) 0.79
Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trial. Parkinsonism Relat Disord (2012) 0.79
Essential oil from Zanthoxylum tingoassuiba loaded into multilamellar liposomes useful as antimicrobial agents. J Microencapsul (2009) 0.78
Kallidin (lysylbradykinin), the kinin formed from horse plasma by horse urinary kallikrein. Biochem Pharmacol (1971) 0.78
Acute turpentine inflammation and kinin release in rat-paw thermic oedema. Br J Exp Pathol (1981) 0.78
Inactivation of kinins by chymotrypsin. Biochem Pharmacol (1976) 0.78
[Health-economic burden of Parkinson's disease in Portugal: a cohort study]. Rev Neurol (2011) 0.78
Growth hormones. II. Structure-function relationships. Reprod Nutr Dev (1989) 0.77
Safety and tolerability of pardoprunox, a new partial dopamine agonist, in a randomized, controlled study of patients with advanced Parkinson's disease. Eur Neurol (2009) 0.77
Acute behavioural comparisons of toluene and ethanol in human subjects. Br J Ind Med (1991) 0.77
Catabolism of vasoactive polypeptides by perfused rat liver. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.76
Prophylactic antibiotics and anticonvulsants in neurosurgery. Adv Tech Stand Neurosurg (2011) 0.76
[Influence of placebo effect on planning and analysis of clinical trials]. Rev Port Cardiol (2001) 0.75
Commentary on "Health economics and the value of therapy in Alzheimer's disease." Value therapy for Alzheimer's disease--a European perspective. Alzheimers Dement (2007) 0.75
Botulinum toxin and dysphagia. Neurology (1992) 0.75
Binding of tritiated methylated luteinizing hormone to bovine corpus luteum receptors. Acta Endocrinol (Copenh) (1976) 0.75
Bradykinin inactivation by perfused rat liver. Role of a thiol activated endopeptidase. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.75
[Possibilities offered by the medical studies]. Rev Assoc Med Bras (1967) 0.75
Further characterization of two arylaminopeptidases from human liver [proceedings]. An Acad Bras Cienc (1978) 0.75
[Etiopathogeny of Parkinson disease. The MPTP revolution]. Acta Med Port (1989) 0.75
Modulation of juvenile rat ovarian adenylate cyclase activity by calcium and calmodulin. Reprod Nutr Dev (1986) 0.75
LH receptors in ovine corpora lutea in relation to various physiological states and effects PGF-2 alpha on LH-induced steroidogenesis in vitro. J Reprod Fertil (1981) 0.75
[Graduation and post-graduation]. AMB Rev Assoc Med Bras (1975) 0.75
Parkinson's disease before age 30. Adv Neurol (1993) 0.75
Studies of the binding activity to different gonadal receptors of ovine luteinizing hormone (LH) after chemical modification of lysine residues. Gen Comp Endocrinol (1977) 0.75
Lysosome injury by perfusion of the isolated rat liver with ethanol or a molasses distillate (cachaça). Braz J Med Biol Res (1983) 0.75
Identification of receptors in the liver that mediate endocytosis of circulating tissue kallikreins. Biochim Biophys Acta (1989) 0.75
Kinin liberation from equine plasma by acidification and neutralization. An Acad Bras Cienc (1970) 0.75
Inhibition by ions of the esterolytic activity of horse urinary kallikrein. Med Pharmacol Exp Int J Exp Med (1966) 0.75
Studies on the inactivation of vasoactive polypeptides by pyridoxal-5'-phosphate. Arch Int Pharmacodyn Ther (1979) 0.75
[Steroidogenic action of 2 analogs of ovine LH on cells isolated from ovine corpus luteum]. Pathol Biol (Paris) (1985) 0.75
[Isolation of protein kinase C isoforms from human full-term placenta]. Ann Endocrinol (Paris) (1991) 0.75
[Critical assessment of articles on controlled clinical trials II. Results]. Acta Med Port (1999) 0.75
Catabolism of vasoactive peptides and a rat liver endopeptidase. Adv Exp Med Biol (1979) 0.75
[Cardiac effects of acute poisoning with tricyclic antidepressants: systematic review of the literature -- Part II]. Rev Port Cardiol (2001) 0.75
Receptor-mediated clearance of tissue kallikreins by rat liver. Adv Exp Med Biol (1986) 0.75
Proceedings: Kinin-converting enzyme from human serum. Acta Physiol Lat Am (1973) 0.75
A comparative study of the action of several lutropin derivatives on rat Leydig cells. Acta Endocrinol (Copenh) (1980) 0.75
Local peri-lesional therapy with rhGM-CSF for Kaposi's sarcoma. Lancet (1993) 0.75
Characterization of two aminopeptidases from human liver [proceedings]. Agents Actions (1978) 0.75
Movement Disorders Cochrane Collaborative Review Group. Mov Disord (1997) 0.75
[Cardiac effects of acute poisoning with tricyclic antidepressants: systematic review of the literature -- Part IV]. Rev Port Cardiol (2001) 0.75
Purification and characterization of the alpha form of rat plasma kallikrein. Braz J Med Biol Res (1987) 0.75
Pilot study of the combination of melphalan, carboplatin and etoposide as a conditioning regimen for relapsed lymphoma patients. Acta Haematol (1999) 0.75
[Cardiac effects of acute poisoning with tricyclic antidepressants: systematic review of the literature -- Part III]. Rev Port Cardiol (2001) 0.75
Rat plasma kallikrein clearance by perfused rat liver. Braz J Med Biol Res (1985) 0.75
[Cardiac effects of acute poisoning with tricyclic antidepressants: systematic review of the literature. Part I]. Rev Port Cardiol (2001) 0.75
Involvement of lysine residues in the binding of ovine chorionic somatomammotropin to lactogenic and somatotropic receptors. FEBS Lett (1984) 0.75
Action of nitroguanidinated luteinizing hormone on different rat gonadal tissues. Mol Cell Endocrinol (1983) 0.75
[Mechanisms linked to the synthesis of steroids in the gonads during stimulation by gonadotropins: correlations between biological activities of various derivatives of luteinizing hormone (LH)]. Pathol Biol (Paris) (1980) 0.75
Ions and the kininogenic activity of horse urinary kallikrein. Acta Physiol Lat Am (1965) 0.75
[Purification, various properties and specificity of equine urinary kallikrein]. An Acad Bras Cienc (1970) 0.75
Rat liver kininases. Partial characterization [proceedings]. An Acad Bras Cienc (1978) 0.75
Action of some luteinizing hormone derivatives in ovaries from pseudopregnant rats: dissimilarities between their activities on this organ and on Leydig cells. J Endocrinol (1983) 0.75
Recovery and conversion of kinins in exsanguinated rat preparations. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.75
Ex utero intrapartum procedure for delivery of a fetus with a large cervical mass. Eur J Anaesthesiol (2005) 0.75
Anticonvulsants for preventing seizures in patients with chronic subdural haematoma. Cochrane Database Syst Rev (2005) 0.75
[Biomedical sciences and post-graduate studies]. AMB Rev Assoc Med Bras (1970) 0.75
Caiman crocodilus yacare plasma kininogen detection. Immunopharmacology (1996) 0.75